Hello! I'll be in Lisbon for #ECCMID2022 with JMI Laboratories. Here's a list of my posters and presentations. Love to see you there.

I'll tweet snippets from my #ECCMID2022 posters over the next few days. Research was supported by AbbVie, JMI Laboratories, Nabriva Therapeutics, and Pfizer Inc..

From "Comparative Activity of Newer B-lactam/B-lactamase Inhibitor Combinations against Pseudomonas aeruginosa from Patients in ICUs of US Medical Centres in 2021" AbbVie #ECCMID2022 See the full presentation here: jmilabs.com/data/posters/E…

From "Antimicrobial Susceptibility of Enterobacterales Causing Infections in Intensive Care Unit Patients: The Role of New B-Lactamase Inhibitor Combinations" AbbVie #ECCMID2022 See the full presentation here: jmilabs.com/data/posters/E…

From "Antimicrobial Activity of Dalbavancin and Comparators against Gram-positive Bacteria Causing Bacteraemia in Patients with Skin and Skin Structure Infections (2017-2021)" AbbVie #ECCMID2022 See the full presentation here: jmilabs.com/data/posters/2…

From "Antimicrobial Activity of Aztreonam-avibactam and Comparator Agents against Ceftazidime-avibactam-resistant Enterobacterales (2019-2021)" Pfizer Inc. #eccmid2022 See the full presentation here: jmilabs.com/data/posters/E…

From "Lefamulin Activity against a Contemporary Global Collection of Staphylococcus aureus (SENTRY 2020-2021)" Nabriva Therapeutics #ECCMID2022 See the full presentation here: jmilabs.com/data/posters/2…

From "Lefamulin Activity against Bacterial Pathogens Typically Causing Pneumonia Collected from European Medical Centres in 2020 and 2021" Nabriva Therapeutics #ECCMID2022 See the full presentation here: jmilabs.com/data/posters/2…

From "Bloodstream infections in Europe: Aetiology and Antimicrobial Susceptibility Results from the SENTRY Antimicrobial Surveillance Program (2019-2021)" JMI Laboratories #ECCMID2022 See the full presentation here: jmilabs.com/data/posters/E…

From "Antimicrobial Susceptibility of Organisms Isolates from Complicated UTI in Europe: Results from the SENTRY Antimicrobial Surveillance Program (2019-2021)" JMI Laboratories #ECCMID2022 See the full presentation here: jmilabs.com/data/posters/E…

Thank you!

It's been a busy few months. A few weeks ago on May 17 I presented "New BL/BLI Combos against Pseudomonas aeruginosa and Enterobacterales from Patients with Pneumonia in Intensive Care Units" at American Thoracic Society (ATS) tinyurl.com/2byfrwh3

.Helio Sader's most recent article out BSAC: Antimicrobial activity of cefepime/zidebactam (WCK 5222), a β-lactam/β-lactam enhancer combination, against clinical isolates of Gram-negative bacteria collected worldwide (2018–19) doi.org/10.1093/jac/dk…